Comparable stake leader
Hugh Griffith
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001709626.
Comparable stake leader
Hugh Griffith
Disclosed value leader
Hugh Griffith
Comparable rows
5/17
Latest evidence
30 Jun 2026
Ownership snapshot
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Quick read
5 of 17 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Hugh Griffith |
13D/G
3/4/5
Hugh S. Griffith · Chief Executive Officer, Director
|
12%
|
$84,898,857
2,829,961,890 shares
|
$0 | 20 Jun 2025 |
| SOFINNOVA CAPITAL VI FCPR |
13D/G
|
5.1%
|
$2,793,266
4,987,975 shares
|
$0 | 14 Feb 2025 |
| Carlyle Group Inc. |
13D/G
The Carlyle Group Inc.
|
2.4%
|
$1,920,835
3,430,062 shares
|
$0 | 18 Apr 2025 |
| Martin C.b. Mellish |
3/4/5
Director
|
0%
|
—
28 shares
|
— | 18 Mar 2026 |
| Elliott M. Levy |
3/4/5
Director
|
0%
|
—
13 shares
|
— | 19 Jun 2026 |
| StoneX Group Inc. |
13F
Company
|
—
class O/S missing
|
$71,510
47,043 shares
|
— | 30 Jun 2026 |
| CITADEL ADVISORS LLC |
13F
Company
|
—
class O/S missing
|
$41,190
27,099 shares
|
— | 30 Jun 2026 |
| HRT FINANCIAL LP |
13F
Company
|
—
class O/S missing
|
$25,000
16,870 shares
|
— | 30 Jun 2026 |
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 27 Aug 2025.
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Showing 1-9 of 9 reporting-owner rows connected to NuCana plc. Open a relationship link for the CIK-to-CIK filing trail.
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Hugh Griffith | Chief Executive Officer, Director | $30,000 | Mixed | 18 Mar 2026 | ||
| Jeffrey D. Bloss | Chief Medical Officer | $1,414 | Mixed | 19 Jun 2026 | ||
| Elliott M. Levy | Director | $0 | Mixed | 19 Jun 2026 | ||
| Martin C.b. Mellish | Director | $0 | Mixed | 18 Mar 2026 | ||
| Ian Alexander Webster | Exhibit 24.1 - Power of Attorney Interim Chief Financial Officer | Mixed | 18 Mar 2026 | |||
| Cyrille Leperlier | Director | Mixed | 18 Mar 2026 | |||
| Theresa Margaret Ms Bruce | Chief Operating Officer | Mixed | 15 Apr 2026 | |||
| David James Harrison | Head of Translational Medicine | Mixed | 18 Mar 2026 | |||
| Andrew Martin Kay | Director | Mixed | 18 Mar 2026 |
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Elliott M. Levy | NCNA | Options | Disposed to Issuer | -100% | -23,811,896 | 0 | 19 Jun 2026 | Direct | ||
| Jeffrey D. Bloss | NCNA | Options | Disposed to Issuer | -25% | -36,539,720 | 109,619,160 | 19 Jun 2026 | Direct | ||
| Theresa Margaret Ms Bruce | NCNA | Options | Award | 132,600,130 | 132,600,130 | 15 Apr 2026 | Direct |